Helicore

Helicore Bio is developing long-acting therapies in obesity and cardiometabolic disease using our proprietary antibody-peptide conjugate platform

Biotech & Life Sciences

Sector

Seed

Stage

Biotechnology

Model

01Company Overview

Helicore Bio is developing long-acting therapies in obesity and cardiometabolic disease using our proprietary antibody-peptide conjugate platform.

02Backed By1 investor

03Similar Companies

HB

Helicore Biopharma

Biotech & Life Sciences

→

OP

IT

ST

A

04Startup DNA

9

signals

Sectors
Business Model
Technology